Navigation Links
Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
Date:1/12/2010

t and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of D-tagatose, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop D-tagatose may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our current report on Form 8-K filed on October 10, 2007.  Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release.  We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

1. Guidance for Industry Diabetes Mellitus — Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) December 2008.

2. Guidance for Industry Diabetes Mellitus: Developing Drugs and Therapeutic Biologics for Treatment and Prevention, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug E
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
2. Spherix Reports Third Quarter 2009 Earnings
3. Spherix Announces Positive Phase 2 Study Results
4. Spherix Reports First Quarter 2009 Earnings
5. Spherix Elects New Independent Director, and Elects Chairman of the Board
6. Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data
7. Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S.
8. Spherix D-tagatose to be Supplied by Inalco SpA
9. Growth Achieved in Spherixs Health Sciences Consulting Business
10. Spherix Reports Second Quarter Earnings
11. Dune Medical Completes Enrollment in MarginProbe(TM) Pivotal Trial for Real-Time Detection of Cancer During Breast Conservation Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  Today the U.S. Food and Drug Administration (FDA) ... of serogroup B meningococcal disease in individuals ... which received FDA approval in October, represent a significant ... "I have heard over and over from ...
(Date:1/23/2015)... Partnership to Fight Chronic Disease (PFCD) released a public opinion poll ... new study analyzing the impact of increased cost sharing on patient ... to educate policy makers and the public on the costs of ... how the Iowa healthcare exchange could be ...
(Date:1/23/2015)... ATLANTA , Jan. 23, 2015 More than a ... a quarter of those with private insurance, filled a prescription ... to a report in this week,s Morbidity and Mortality Weekly ... health care providers to treat moderate to severe pain.  They ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... BRIDGEWATER, N.J., Oct. 8 Advanced Health Media, LLC ... marketing services and related technology for the pharmaceutical and ... industry leader in speaker bureau management, supplying automation and ... and coordinating promotional events for more than 200 brands. ...
... Oct. 8 Cancer treatments are on track to become ... to overall drug spending hit five percent for the first ... Health Solutions, Inc. (NYSE: MHS). Oncology specialty drug spending ... conditions and multiple sclerosis as a specialty drug growth driver. ...
Cached Medicine Technology:Advanced Health Media Announces Acquisition of Ephikacy, LLC 2Advanced Health Media Announces Acquisition of Ephikacy, LLC 3Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 2Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 3Cancer Drugs Emerging as Top Driver of Specialty Drug Spending 4
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... over 20 years, Dr. David Cruz of Cruz Chiropractic Care ... just about every type of injury that can result from car ... twenty-plus years, the team at Doctors on Liens has ... doctor. With the combined breadth of experience between the ...
(Date:1/22/2015)... 2015 Recently, Weddingshe.com has added many trendy ... announced its highest annual revenues in the past three years. ... glamorous wedding dresses. , According to the sales manager of ... promotions for them in 2015. This point can be reflected ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 As interest ... overall health care gains momentum worldwide, Rev. Eric J. ... HealthCare Chaplaincy Network (HCCN), will be the keynote speaker ... care in Israel’s public health system. , The conference, “Hope ...
(Date:1/22/2015)... 22, 2015 State Forestry Institute of ... system with support from GEOSYSTEMS, a dedicated Hexagon Geospatial ... will leverage Hexagon Geospatial’s ERDAS APOLLO for ... well as point clouds and documents. This effort will ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... Gordon HealthDay Reporter , TUESDAY, Jan. 24 ... heartburn and other signs of gastroesophageal reflux don,t get ... research. And, taking these medications when there ... developing a respiratory infection, reports the study. "There,s ...
... least 10 percent of students at a single college could ... live off campus are drinking more and engaging in more ... research suggests. In contrast, hosts of parties held on ... their gatherings, according to the study. The research also ...
... 24 (HealthDay News) -- If you have gout, drinking enriched ... new research suggests. The new study included 120 patients ... four months. They were divided into three treatment groups that ... powder enriched with glycomacropeptide (GMP) and G600 milk fat extract ...
... HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay News) -- New ... enlarged prostate gland, may help slow the progression of early ... some men. Prostate cancer can grow and spread slowly, ... so-called watchful waiting when the cancer is first diagnosed. Avodart ...
... paper from Rhode Island Hospital reports on the impact ... the upcoming revision to the Diagnostic and Statistical Manual, ... believe these changes could result in false-negative diagnoses for ... of Clinical Psychiatry and is now available online ...
... 2012, the annual scientific meeting of the American College ... health care journalists. Don,t miss the opportunity to report ... physician group in the United States. More than 250 ... its subspecialties, and issues in practice management and health ...
Cached Medicine News:Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 2Health News:Heartburn Meds Won't Help, May Harm Kids With Asthma 3Health News:Study: Off-campus college party hosts drink more than attendees 2Health News:Study: Off-campus college party hosts drink more than attendees 3Health News:Enriched Skim Milk Good for Gout, Study Suggests 2Health News:Drug May Slow Early Prostate Cancer: Study 2Health News:The impact of deleting 5 personality disorders in the new DSM-5 2
Delicate strong curved serrated tips. Serrated handle with dull finish....
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
Two 2.75 mm long tips separated 1 mm with 1 x 2 teeth. Serrated handle with dull finish....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
Medicine Products: